IkT-001Pro
IkT-001Pro-702
Phase 2 small_molecule terminated
Quick answer
IkT-001Pro for Pulmonary Arterial Hypertension (PAH) is a Phase 2 program (small_molecule) at Inhibikase Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Inhibikase Therapeutics
- Indication
- Pulmonary Arterial Hypertension (PAH)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated